Leiomyoma of uterus. benign neoplasms of uterus with morphology code M889 and behaviour code /0 fibromyoma of uterus
Conditions
Interventions
Intervention 1: The procedure is described to patients and council form is taken. An evaluation sheet including history, para clinic and out comes is filled out for all of women who were scheduled
Treatment - Drugs
The procedure is described to patients and council form is taken. An evaluation sheet including history, para clinic and out comes is filled out for all of women who were scheduled to undergo myome
Sponsors
Vice chancellor for research,Shiraz University of Medical Sciences
Eligibility
Sex/Gender
Female
Age
18 Years to 55 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: 18-55 years old women; with symptomatic uterine mayoma; with out any contraindication for laparoscopy, Misoprostol or Vasopressine Exclusion criteria:any contraindication for laparoscopy; any contraindication for Misoprostol; any contraindication for Vasopressine;
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Blood loss during surgery. Timepoint: End of surgery. Method of measurement: Volume of blood in suction & bloody sponge count.;Hb drop after surgery. Timepoint: Befor & 6 hour after surgery. Method of measurement: gr/ dl from blood specimen; before and 6 hour after surgery. | — |
Secondary
| Measure | Time frame |
|---|---|
| Post operative complication. Timepoint: From transfer of patient to ward till two weeks after surgery. Method of measurement: Incidence pf complication be mentioned.;Surgical complication. Timepoint: During surgery. Method of measurement: Incidence pf complication be mentioned.;Duration of operation. Timepoint: At the time of surgery. Method of measurement: From inserting first trocar to skin suturing, by minute.;Hemodynamic changes during surgery. Timepoint: During surgery. Method of measurement: Mean of vital sign recorded by Anesthesiologist; mm Hg(blood pressure) puls rate per minute( heat rate), centigrade( temperature).;Administration of another uterotonic agent. Timepoint: During surgery. Method of measurement: Number of injection.;Post operative fever. Timepoint: From transfer of patient to ward till discharge time. Method of measurement: Record of temp. above 37.8 centigrade during hospitalization. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactParnian Kord Jamshidi
Shiraz university of medical since
Outcome results
None listed